WHAT IS UTERINE FIBROIDS? DOES MYOMA TURN INTO CANCER?

Reading time is 2 mins

.
.
WHAT IS UTERINE FIBROIDS? DOES MYOMA TURN INTO CANCER?

What is uterine fibroids? How do you know if you have uterine fibroids? Does myoma turn into cancer? Turkey Medicals member and Marmaris hospital Obstetrics, Gynecology and Gynecology Oncology Specialist Assoc. Dr. gave detailed information about the topic of uterine fibroids.

Myoma is a benign tumor

Uterine fibroids are benign tumors that occur especially in women during the fertile period (usually between the ages of 30-40). Almost one in every 3 women of childbearing age has the problem of uterine fibroids. The symptoms caused by the myoma problem, which is commonly experienced Dec women, vary according to its size and the region where it is located. While in many cases it does not cause any complaints, in some women it can lead to irregular and excessive bleeding, abdominal pain, and urinary problems.

It should not be neglected that it is harmless!

Treatment is not necessary for every woman who has a uterine fibroids problem. Many of the patients can only be followed up without treatment.. But this does not mean that in the presence of uterine fibroids in women, they should ignore this problem Dec A woman who feels different in her body and suspects uterine fibroids should contact a doctor who is an expert in this field and follow the doctor’s instructions. Especially in a woman planning a pregnancy, fibroids that have settled in the inner layer of the uterus may need to be removed in advance. Otherwise, these fibroids can lead to pregnancy complications such as recurrent miscarriage, premature birth.

How do I know if I have uterine fibroids?

One of the issues that women are most interested in is the question of how to tell if they have fibroids in their uterus. Myoma, which makes its presence felt by different effects in each woman according to its size, number and location, can cause the following complaints.

– Excessive menstrual bleeding (intense and clotted)

– Disruption of the menstrual cycle

– Recurrent pain and cramping in the lower abdomen

– Accompanied by pain in the abdomen, bloating, a feeling of pressure and pressure

– Pain in the groin area

– Leg and back pain

– Frequent urination

– Constipation and digestive problems

– Pain during sexual intercourse

– Infertility or recurrent miscarriage.

The goal of the drug is to eliminate the complaint!

For fibroids; medication (anti-inflammatory, implant, birth control pill, hormonal spiral, etc.) many different treatment methods can be applied, such as uterine vein embolization, surgical procedure. The aim of the drug treatment is to eliminate the problems experienced, that is, the complaints of the patient. These methods of treatment do not reduce fibroids or reduce their number.

Women who want to become mothers

The problem of uterine fibroids can lead to complete removal of the uterus of women, especially in Turkey. This is also seen as a sad event for women who want to have children in the future. Considering these conditions and requests, we surgeons perform operations that ensure the protection of the uterus in these patients. During the operation, we remove only fibroids, without touching the uterus. We also call this operation myomectomy.

Myomectomy surgery is a very comfortable procedure. In appropriate patients, the patient is discharged within the same day with laparoscopic (closed method) myomectomy. In addition, while the recovery period lasts shorter, more aesthetic results can be obtained in terms of scarring.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)